Joseph Podojil, Ph.D.

Research Associate Professor, Director of Immunology
Northwestern University, Cour Pharmaceuticals

Poster(s):

• Th192 - Therapeutic Treatment with PLGA Nanoparticles Containing a Single CD4+ Epitope Reverses CD8+ T Cell-induced Type I Diabetes Disease Progression
  Thursday, June 26, 2025

  7:30am - 7:45pm East Coast USA Time

• Tu215 - STING and IFN-alpha/beta Receptor Are Required for Antigen-specific Apoptotic Cell-induced Peripheral Tolerance
  Tuesday, June 24, 2025

  6:00pm - 7:30pm East Coast USA Time